NO20033540D0 - 6-substituerte pyrido-pyrimidiner - Google Patents

6-substituerte pyrido-pyrimidiner

Info

Publication number: NO20033540D0
Authority: NO; Norway
Prior art keywords: pyrimidines; substituted pyrido; pyrido; substituted
Prior art date: 2001-02-12

Application number

NO20033540A

Other languages

English (en)

Other versions

NO326133B1 (no

NO20033540L (no

Inventor

Jeffrey Jian Chen

James Patrick Dunn

David Michael Goldstein

Christophe Martin Stahl

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-12

Filing date

2003-08-11

Publication date

2003-08-11

2003-08-11 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2003-08-11 Publication of NO20033540L publication Critical patent/NO20033540L/no

2003-08-11 Publication of NO20033540D0 publication Critical patent/NO20033540D0/no

2008-10-06 Publication of NO326133B1 publication Critical patent/NO326133B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20033540A 2001-02-12 2003-08-11 6-substituerte pyrido-pyrimidiner, fremgangsmate for fremstilling av slike, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom NO326133B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US26837501P	2001-02-12	2001-02-12
US33465401P	2001-11-30	2001-11-30
PCT/EP2002/001106 WO2002064594A2 (en)	2001-02-12	2002-02-04	6-substituted pyrido-pyrimidines

Publications (3)

Publication Number	Publication Date
NO20033540L NO20033540L (no)	2003-08-11
NO20033540D0 true NO20033540D0 (no)	2003-08-11
NO326133B1 NO326133B1 (no)	2008-10-06

Family

ID=26953040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033540A NO326133B1 (no)	2001-02-12	2003-08-11	6-substituerte pyrido-pyrimidiner, fremgangsmate for fremstilling av slike, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom

Country Status (31)

Country	Link
US (3)	US6696566B2 (no)
EP (1)	EP1361880B1 (no)
JP (1)	JP4064818B2 (no)
KR (1)	KR100639772B1 (no)
CN (1)	CN100376571C (no)
AR (1)	AR035854A1 (no)
AT (1)	ATE305303T1 (no)
AU (1)	AU2002256615B2 (no)
BR (1)	BRPI0207172B8 (no)
CA (1)	CA2434834C (no)
CZ (1)	CZ20032416A3 (no)
DE (1)	DE60206363T2 (no)
DK (1)	DK1361880T3 (no)
ES (1)	ES2249574T3 (no)
HR (1)	HRP20030624B1 (no)
HU (1)	HU229604B1 (no)
IL (2)	IL156872A0 (no)
JO (1)	JO2410B1 (no)
MA (1)	MA26993A1 (no)
MX (1)	MXPA03007166A (no)
MY (1)	MY131518A (no)
NO (1)	NO326133B1 (no)
NZ (1)	NZ526961A (no)
PA (1)	PA8539201A1 (no)
PE (1)	PE20020976A1 (no)
PL (1)	PL366918A1 (no)
RU (1)	RU2269527C2 (no)
SK (1)	SK11322003A3 (no)
WO (1)	WO2002064594A2 (no)
YU (1)	YU63703A (no)
ZA (1)	ZA200305938B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7053070B2 (en) *	2000-01-25	2006-05-30	Warner-Lambert Company	Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
YU63703A (sh)	2001-02-12	2006-05-25	F. Hoffmann-La Roche Ag.	6-supstituisani pirido-pirimidini
PL218692B1 (pl)	2002-01-22	2015-01-30	Warner Lambert Co	Podstawiony 2-(pirydyn-2-yloamino)pirydo[2,3-d]pirymidyn-7-on oraz jego zastosowanie do leczenia zaburzenia lub stanu spowodowanego nieprawidłową proliferacją komórek
JP2006503802A (ja)	2002-04-03	2006-02-02	エフ．ホフマン−ラ　ロシュ　アーゲー	イミダゾ縮合化合物
JP4252534B2 (ja)	2002-08-06	2009-04-08	エフ．ホフマン−ラロシュアーゲー	ｐ−３８ＭＡＰキナーゼインヒビターとしての６−アルコキシ−ピリド−ピリミジン類
JP2006516548A (ja)	2002-12-30	2006-07-06	アンジオテックインターナショナルアクツィエンゲゼルシャフト	迅速ゲル化ポリマー組成物からの薬物送達法
WO2004076412A2 (en) *	2003-02-26	2004-09-10	Sugen, Inc.	Aminoheteroaryl compounds as protein kinase inhibitors
BRPI0409405A (pt) *	2003-04-16	2006-04-25	Hoffmann La Roche	compostos 7-aza-quinazolina substituìdos
EP1685131B1 (en) *	2003-11-13	2007-03-07	F. Hoffmann-La Roche AG	Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
US20090131430A1 (en) *	2004-11-23	2009-05-21	Palle Venkata P	Pyrido'2,3-dipyrimidines as anti-inflammatory agents
US20060142312A1 (en) *	2004-12-23	2006-06-29	Pfizer Inc	C6-aryl and heteroaryl substituted pyrido[2,3-D] pyrimidin-7-ones
US20090036472A1 (en) *	2005-02-02	2009-02-05	Palle Venkata P	Azabicyclo derivatives as anti-inflammatory agents
MX2007013595A (es) *	2005-05-04	2008-01-24	Renovis Inc	Compuestos heterociclicos fusionados y composiciones y usos de estos.
ATE449097T1 (de) *	2005-07-21	2009-12-15	Hoffmann La Roche	Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
ES2351939T3 (es) *	2005-08-09	2011-02-14	Irm Llc	Compuestos y composiciones como inhibidores de proteínas cinasas.
EP1917245A1 (de)	2005-08-21	2008-05-07	Abbott GmbH & Co. KG	Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
JO2783B1 (en) *	2005-09-30	2014-03-15	نوفارتيس ايه جي	Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones
AU2007268749B2 (en) *	2006-05-26	2012-07-26	Taisho Pharmaceutical Co., Ltd.	Novel heterocyclic compound or salt thereof and intermediate thereof
WO2008150260A1 (en) *	2007-06-06	2008-12-11	Gpc Biotech, Inc.	8-oxy-2-aminopyrido (2, 3-d) pyrimidin-7-one derivatives as kinase inhibitors and anticancer agents
WO2008078249A1 (en) *	2006-12-21	2008-07-03	Ranbaxy Laboratories Limited	Anti-inflammatory agents
CA2685597C (en)	2007-05-07	2012-10-02	Amgen Inc.	Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
JP2010529973A (ja)	2007-06-15	2010-09-02	エフ．ホフマン−ラロシュアーゲー	３−アミノ−ペンタン−１，５−ジオールの新規製造方法
US8367671B2 (en)	2008-03-21	2013-02-05	Amgen Inc.	Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents
EP2112150B1 (en)	2008-04-22	2013-10-16	Forma Therapeutics, Inc.	Improved raf inhibitors
WO2010046273A2 (en) *	2008-10-22	2010-04-29	F. Hoffmann-La Roche Ag	Pyrimidinyl pyridone inhibitors of jnk
WO2010071846A2 (en)	2008-12-19	2010-06-24	Afraxis, Inc.	Compounds for treating neuropsychiatric conditions
CN102648200A (zh) *	2009-10-09	2012-08-22	亚弗克希斯公司	用于治疗cns病症的8-乙基-6-(芳基)吡啶并[2，3-d]嘧啶-7(8h)-酮
JP5797664B2 (ja) *	2009-12-18	2015-10-21	テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションＴｅｍｐｌｅＵｎｉｖｅｒｓｉｔｙ−ＯｆＴｈｅＣｏｍｍｏｎｗｅａｌｔｈＳｙｓｔｅｍＯｆＨｉｇｈｅｒＥｄｕｃａｔｉｏｎ	置換ピリド［２，３−ｄ］ピリミジン−７（８Ｈ）−オン及びそれらの治療用の使用
EP3172214B1 (en)	2014-07-26	2020-05-13	Sunshine Lake Pharma Co., Ltd.	2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as cdk inhibitors and uses thereof
JP7349790B2 (ja) *	2016-06-08	2023-09-25	サポート－ヴェンチャーゲゼルシャフトミットベシュレンクターハフトゥング	がんを治療するための薬学的組み合わせ
MA45920B1 (fr)	2016-08-15	2021-08-31	Pfizer	Inhibiteurs de pyridopyrimidinone cdk2/4/6
JP2019528273A (ja)	2016-08-17	2019-10-10	サポート−ヴェンチャーゲゼルシャフトミットベシュレンクターハフトゥング	聴力損失を予防又は治療する方法
US11117858B2 (en)	2017-01-11	2021-09-14	The General Hospital Corporation	Voltage gated sodium channel imaging agents
US11576916B2 (en) *	2017-04-04	2023-02-14	Kinarus Ag	Methods of preventing or treating ophthalmic diseases
CN115322193A (zh)	2017-08-31	2022-11-11	达纳-法伯癌症研究所股份有限公司	Egfr和/或her2抑制剂和使用方法
PT3691620T (pt)	2017-10-05	2022-10-06	Fulcrum Therapeutics Inc	Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2020006210A1 (en) *	2018-06-27	2020-01-02	Tufts Medical Center, Inc.	Pyridopyrimidine compounds and methods of their use
EA202092888A1 (ru)	2018-07-13	2021-04-19	Кинарус Аг	КОМБИНАЦИИ АГОНИСТОВ PPAR И ИНГИБИТОРОВ КИНАЗЫ p38 ДЛЯ ПРЕДОТВРАЩЕНИЯ ИЛИ ЛЕЧЕНИЯ ФИБРОЗИРУЮЩИХ ЗАБОЛЕВАНИЙ
TW202112368A (zh)	2019-06-13	2021-04-01	荷蘭商法西歐知識產權股份有限公司	用於治療有關dux4表現之疾病的抑制劑組合
US20230263803A1 (en)	2020-08-11	2023-08-24	Kinarus Ag	Methods of preventing or treating covid-19 and related viral diseases or disorders
CN120247910A (zh) *	2025-04-01	2025-07-04	赣南师范大学	一种杂环类化合物及其制备方法、应用和防治肿瘤的药物组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4215216A (en)	1979-04-18	1980-07-29	American Home Products Corporation	7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
US5037826A (en)	1986-10-15	1991-08-06	Schering Corporation	1-substituted naphthyridine and pyridopyrazine derivatives
GB8702758D0 (en) *	1987-02-06	1987-03-11	Wellcome Found	Treatment of disease
AU598093B2 (en)	1987-02-07	1990-06-14	Wellcome Foundation Limited, The	Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
JP2550456B2 (ja) *	1990-11-06	1996-11-06	山之内製薬株式会社	縮合ピラジン誘導体
WO1993017682A1 (en)	1992-03-04	1993-09-16	Abbott Laboratories	Angiotensin ii receptor antagonists
TW299333B (no) *	1992-12-29	1997-03-01	Takeda Pharm Industry Co Ltd
ES2146782T3 (es) *	1994-11-14	2000-08-16	Warner Lambert Co	6-aril-pirido(2,3-d)pirimidinas y naftiridinas para la inhibicion de la proliferacion celular inducida por la proteina tirosina quinasa.
IL115256A0 (en) *	1994-11-14	1995-12-31	Warner Lambert Co	6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
US5620981A (en)	1995-05-03	1997-04-15	Warner-Lambert Company	Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) *	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
AR004010A1 (es)	1995-10-11	1998-09-30	Glaxo Group Ltd	Compuestos heterociclicos
US6107300A (en)	1996-03-27	2000-08-22	Dupont Pharmaceuticals	Arylamino fused pyrimidines
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5945422A (en)	1997-02-05	1999-08-31	Warner-Lambert Company	N-oxides of amino containing pyrido 2,3-D! pyrimidines
ES2301194T3 (es)	1997-02-05	2008-06-16	Warner-Lambert Company Llc	Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular.
TW458977B (en) *	1997-04-16	2001-10-11	Abbott Lab	6,7-disubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
CA2286592A1 (en)	1997-04-16	1998-10-22	Abbott Laboratories	5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
PL336304A1 (en)	1997-04-16	2000-06-19	Abbott Lab	5,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds and their application as adenosine kinase inhibitors
EE200000706A (et)	1998-05-26	2002-06-17	Warner-Lambert Company	Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
WO1999065908A1 (en)	1998-06-19	1999-12-23	Pfizer Products Inc.	PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
EP1078923B1 (en)	1999-08-02	2006-03-08	F. Hoffmann-La Roche Ag	Process for the preparation of benzothiophene derivatives
US7053070B2 (en) *	2000-01-25	2006-05-30	Warner-Lambert Company	Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
CA2401368A1 (en) *	2000-03-06	2001-09-27	Warner-Lambert Company	5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
US6518276B2 (en) *	2000-08-31	2003-02-11	Syntex (U.S.A.) Llc	7-oxo-pyridopyrimidines (II)
YU63703A (sh)	2001-02-12	2006-05-25	F. Hoffmann-La Roche Ag.	6-supstituisani pirido-pirimidini
PL218692B1 (pl) *	2002-01-22	2015-01-30	Warner Lambert Co	Podstawiony 2-(pirydyn-2-yloamino)pirydo[2,3-d]pirymidyn-7-on oraz jego zastosowanie do leczenia zaburzenia lub stanu spowodowanego nieprawidłową proliferacją komórek

2002
- 2002-02-04 YU YU63703A patent/YU63703A/sh unknown
- 2002-02-04 IL IL15687202A patent/IL156872A0/xx unknown
- 2002-02-04 CA CA2434834A patent/CA2434834C/en not_active Expired - Lifetime
- 2002-02-04 DK DK02726103T patent/DK1361880T3/da active
- 2002-02-04 DE DE60206363T patent/DE60206363T2/de not_active Expired - Lifetime
- 2002-02-04 HR HR20030624A patent/HRP20030624B1/xx not_active IP Right Cessation
- 2002-02-04 WO PCT/EP2002/001106 patent/WO2002064594A2/en not_active Ceased
- 2002-02-04 AT AT02726103T patent/ATE305303T1/de active
- 2002-02-04 KR KR1020037010562A patent/KR100639772B1/ko not_active Expired - Lifetime
- 2002-02-04 AU AU2002256615A patent/AU2002256615B2/en not_active Expired
- 2002-02-04 BR BR0207172-0 patent/BRPI0207172B8/pt not_active IP Right Cessation
- 2002-02-04 SK SK11322003A patent/SK11322003A3/sk unknown
- 2002-02-04 JP JP2002564525A patent/JP4064818B2/ja not_active Expired - Lifetime
- 2002-02-04 CN CNB028048342A patent/CN100376571C/zh not_active Expired - Lifetime
- 2002-02-04 NZ NZ526961A patent/NZ526961A/en unknown
- 2002-02-04 ES ES02726103T patent/ES2249574T3/es not_active Expired - Lifetime
- 2002-02-04 MX MXPA03007166A patent/MXPA03007166A/es active IP Right Grant
- 2002-02-04 CZ CZ20032416A patent/CZ20032416A3/cs unknown
- 2002-02-04 PL PL02366918A patent/PL366918A1/xx not_active Application Discontinuation
- 2002-02-04 RU RU2003125887/04A patent/RU2269527C2/ru not_active IP Right Cessation
- 2002-02-04 HU HU0303458A patent/HU229604B1/hu unknown
- 2002-02-04 EP EP02726103A patent/EP1361880B1/en not_active Expired - Lifetime
- 2002-02-06 JO JO200212A patent/JO2410B1/en active
- 2002-02-08 PE PE2002000097A patent/PE20020976A1/es not_active Application Discontinuation
- 2002-02-08 PA PA20028539201A patent/PA8539201A1/es unknown
- 2002-02-11 US US10/073,845 patent/US6696566B2/en not_active Expired - Lifetime
- 2002-02-11 MY MYPI20020491A patent/MY131518A/en unknown
- 2002-02-11 AR ARP020100430A patent/AR035854A1/es unknown
2003
- 2003-07-10 IL IL156872A patent/IL156872A/en unknown
- 2003-07-31 ZA ZA2003/05938A patent/ZA200305938B/en unknown
- 2003-08-11 NO NO20033540A patent/NO326133B1/no not_active IP Right Cessation
- 2003-08-11 MA MA27273A patent/MA26993A1/fr unknown
- 2003-11-25 US US10/722,703 patent/US7169794B2/en not_active Expired - Lifetime
2007
- 2007-01-09 US US11/651,302 patent/US7449581B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2249574T3 (es)	2006-04-01
MXPA03007166A (es)	2003-11-18
HUP0303458A2 (hu)	2004-01-28
US20040116698A1 (en)	2004-06-17
DE60206363D1 (de)	2006-02-09
RU2269527C2 (ru)	2006-02-10
HU229604B1 (en)	2014-02-28
BRPI0207172B1 (pt)	2019-04-09
CA2434834C (en)	2010-09-14
KR100639772B1 (ko)	2006-10-30
NO326133B1 (no)	2008-10-06
JP2004525896A (ja)	2004-08-26
US20030171584A1 (en)	2003-09-11
HUP0303458A3 (en)	2012-12-28
PL366918A1 (en)	2005-02-07
NZ526961A (en)	2005-03-24
ATE305303T1 (de)	2005-10-15
ZA200305938B (en)	2005-01-26
JP4064818B2 (ja)	2008-03-19
NO20033540L (no)	2003-08-11
RU2003125887A (ru)	2005-03-20
US7449581B2 (en)	2008-11-11
BR0207172A (pt)	2004-03-30
US7169794B2 (en)	2007-01-30
YU63703A (sh)	2006-05-25
MY131518A (en)	2007-08-30
BRPI0207172B8 (pt)	2021-05-25
JO2410B1 (en)	2007-06-17
US20070135458A1 (en)	2007-06-14
WO2002064594A2 (en)	2002-08-22
PA8539201A1 (es)	2004-08-31
DE60206363T2 (de)	2006-07-06
AR035854A1 (es)	2004-07-21
HRP20030624B1 (en)	2007-03-31
DK1361880T3 (da)	2006-01-23
CZ20032416A3 (cs)	2004-07-14
MA26993A1 (fr)	2004-12-20
PE20020976A1 (es)	2002-10-29
WO2002064594A3 (en)	2003-01-09
KR20040018254A (ko)	2004-03-02
HK1066170A1 (en)	2005-03-18
US6696566B2 (en)	2004-02-24
EP1361880A2 (en)	2003-11-19
IL156872A0 (en)	2004-02-08
EP1361880B1 (en)	2005-09-28
AU2002256615B2 (en)	2007-09-13
SK11322003A3 (en)	2004-10-05
CN1503672A (zh)	2004-06-09
CN100376571C (zh)	2008-03-26
CA2434834A1 (en)	2002-08-22
IL156872A (en)	2009-07-20
HRP20030624A2 (en)	2005-06-30

Publication	Publication Date	Title
DK1361880T3 (da)	2006-01-23	6-substituerede pyrido-pyrimidiner
ATE402148T1 (de)	2008-08-15	Substituierte pyridinylamine
DE50208022D1 (de)	2006-10-12	Wischblatt
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
DE50204386D1 (de)	2006-02-09	Kreuztransducer
DE50206021D1 (de)	2006-05-04	Schlauchklemme
NO20042742L (no)	2004-08-24	Pyrimidinforbindelser
DE50209238D1 (de)	2007-02-22	Kugelgelenk
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
DE50204551D1 (de)	2005-11-17	Kugelgelenk
DE50208372D1 (de)	2006-11-23	Schrankaufhängevorrichtung
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE50204794D1 (de)	2005-12-08	Kugelgelenk
DE50203412D1 (de)	2005-07-21	Schwenkkolbenverdränger
DE50203984D1 (de)	2005-09-22	Kugelgelenk
DE50208029D1 (de)	2006-10-12	Kugelgelenk
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
NO20034649L (no)	2003-12-17	Silstrammingsanordning
DK1406858T3 (da)	2009-11-23	Substituerede 4-aminocyklohexanoler
DE50201862D1 (de)	2005-01-27	Messwandler
DE50203093D1 (de)	2005-06-16	Losradlager
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
DE50209293D1 (de)	2007-03-08	Amidpolymermasse
DE50209386D1 (de)	2007-03-15	Kugelgelenk
DE50207815D1 (de)	2006-09-21	Kugelgelenk

Legal Events

Date	Code	Title	Description
2010-09-27	MM1K	Lapsed by not paying the annual fees